Hunter Associates Investment Management’s Quest Diagnostics DGX Stock Holding History

Hunter Associates Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$599K	Sell	2,822 -200	-7%	-$39.3K	0.07%	186
2026 Q1	$592K	Hold	3,022	–	–	0.08%	178
2025 Q4	$524K	Hold	3,022	–	–	0.07%	179
2025 Q3	$575K	Hold	3,022	–	–	0.08%	175
2025 Q2	$543K	Hold	3,022	–	–	0.08%	177
2025 Q1	$513K	Hold	3,022	–	–	0.08%	171
2024 Q4	$454K	Sell	3,022 -153	-5%	-$23.8K	0.07%	179
2024 Q3	$494K	Hold	3,175	–	–	0.08%	177
2024 Q2	$434K	Hold	3,175	–	–	0.07%	188
2024 Q1	$423K	Hold	3,175	–	–	0.07%	190
2023 Q4	$438K	Hold	3,175	–	–	0.08%	189
2023 Q3	$387K	Hold	3,175	–	–	0.08%	191
2023 Q2	$446K	Hold	3,175	–	–	0.09%	176
2023 Q1	$449K	Hold	3,175	–	–	0.1%	165
2022 Q4	$497K	Hold	3,175	–	–	0.12%	137
2022 Q3	$389K	Hold	3,175	–	–	0.1%	149
2022 Q2	$421K	Buy	3,175 +1,675	+112%	+$228K	0.1%	142
2022 Q1	$205K	Hold	1,500	–	–	0.07%	134
2021 Q4	$260K	Hold	1,500	–	–	0.07%	127
2021 Q3	$218K	Buy	+1,500	New	+$219K	0.07%	131
2021 Q2	–	Sell	-4,275	Closed	-$549K	–	155
2021 Q1	$549K	Hold	4,275	–	–	0.13%	115
2020 Q4	$509K	Hold	4,275	–	–	0.13%	117
2020 Q3	$489K	Hold	4,275	–	–	0.14%	114
2020 Q2	$487K	Hold	4,275	–	–	0.14%	112
2020 Q1	$343K	Sell	4,275 -600	-12%	-$62.1K	0.13%	109
2019 Q4	$521K	Sell	4,875 -800	-14%	-$83.4K	0.16%	103
2019 Q3	$607K	Hold	5,675	–	–	0.21%	86
2019 Q2	$578K	Hold	5,675	–	–	0.2%	87
2019 Q1	$510K	Hold	5,675	–	–	0.18%	102
2018 Q4	$473K	Sell	5,675 -25	-0.4%	-$2.34K	0.19%	96
2018 Q3	$615K	Hold	5,700	–	–	0.21%	89
2018 Q2	$627K	Hold	5,700	–	–	0.23%	85
2018 Q1	$572K	Hold	5,700	–	–	0.21%	89
2017 Q4	$561K	Hold	5,700	–	–	0.21%	90
2017 Q3	$534K	Sell	5,700 -100	-2%	-$10.6K	0.21%	90
2017 Q2	$645K	Sell	5,800 -200	-3%	-$21.1K	0.26%	76
2017 Q1	$589K	Sell	6,000 -200	-3%	-$19.1K	0.25%	80
2016 Q4	$570K	Hold	6,200	–	–	0.24%	82
2016 Q3	$525K	Hold	6,200	–	–	0.23%	92
2016 Q2	$505K	Buy	6,200 +200	+3%	+$15.2K	0.22%	91
2016 Q1	$429K	Sell	6,000 -300	-5%	-$20.1K	0.2%	98
2015 Q4	$448K	Hold	6,300	–	–	0.2%	92
2015 Q3	$387K	Hold	6,300	–	–	0.18%	100
2015 Q2	$457K	Hold	6,300	–	–	0.19%	99
2015 Q1	$484K	Buy	6,300 +200	+3%	+$14.3K	0.19%	100
2014 Q4	$409K	Sell	6,100 -600	-9%	-$37.9K	0.16%	105
2014 Q3	$407K	Sell	6,700 -120	-2%	-$7.39K	0.16%	105
2014 Q2	$400K	Sell	6,820 -200	-3%	-$11.7K	0.16%	105
2014 Q1	$407K	Sell	7,020 -400	-5%	-$21.4K	0.16%	111
2013 Q4	$397K	Sell	7,420 -653	-8%	-$38.7K	0.15%	114
2013 Q3	$499K	Sell	8,073 -2,507	-24%	-$150K	0.21%	98
2013 Q2	$641K	Buy	+10,580	New	+$630K	0.24%	90

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Hunter Associates Investment Management's DGX Position: Q2 2026 in Review

Hunter Associates Investment Management reduced its Quest Diagnostics (DGX) stake by 6.6% in Q2 2026, selling an estimated $39.3K and leaving 2,822 shares worth $599K. The position accounts for 0.07% of the portfolio, ranked #186.

Hunter Associates Investment Management first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $645K in Q2 2017. 635 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Hunter Associates Investment Management held 2,822 shares of Quest Diagnostics worth $599K as of Q2 2026.
Hunter Associates Investment Management sold 200 Quest Diagnostics shares in Q2 2026, an estimated $39.3K.
Quest Diagnostics made up 0.07% of Hunter Associates Investment Management's portfolio in Q2 2026, its #186 holding.
Hunter Associates Investment Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
Hunter Associates Investment Management's Quest Diagnostics position peaked at $645K in Q2 2017.
635 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.